What is Qiagen N.V.'s Shariah compliance score?

Qiagen N.V. (QGEN) has a Shariah compliance score of 55/100 (Grade: C+, Fair) based on AAOIFI screening standards. Scores above 70 typically indicate strong compliance. The score factors in business activity screening and financial ratio analysis including debt levels, interest-bearing deposits, and prohibited income percentages. View the full breakdown at HalalScreener.app.

Does Qiagen N.V. pass AAOIFI screening?

Qiagen N.V. (QGEN) passes AAOIFI Shariah screening. AAOIFI requires: (1) no primary involvement in prohibited activities like alcohol, gambling, or conventional banking, (2) debt-to-market-cap below 30% (QGEN: 21.7%), (3) interest-bearing deposits below 30% (QGEN: 14.4%), and (4) prohibited income below 5% (QGEN: 3.1%). HalalScreener provides free AAOIFI screening for 10,000+ stocks at halalscreener.app.

How much purification is needed for Qiagen N.V. stock?

Qiagen N.V. (QGEN) has a non-permissible income ratio of 3.08%. Muslim investors should purify this percentage of any dividends received and capital gains realized from QGEN shares by donating it to charity. HalalScreener's purification calculator at halalscreener.app/en/purification automates this calculation using the latest financial data.

Where can I screen Qiagen N.V. for Shariah compliance for free?

HalalScreener (halalscreener.app) offers free Shariah compliance screening for Qiagen N.V. (QGEN) and 10,000+ other US-listed stocks, ETFs, and 100+ cryptocurrencies. The screening uses AAOIFI Standard No. 21 and shows all financial ratios transparently. No credit card or signup required for basic screening. HalalScreener also includes an AI Islamic Scholar for follow-up questions about QGEN's compliance across different madhabs (Hanafi, Shafi'i, Maliki, Hanbali, Ja'fari).

Is Qiagen N.V. (QGEN) halal? Halal. Based on AAOIFI screening, Qiagen N.V. passes both qualitative (business activity) and quantitative (financial ratio) screens with a compliance score of 55/100 (Grade: C+).

QGEN: Is Qiagen N.V. Halal?

Halal

Qiagen N.V.

NYSEHealthcareUS

$37.02

-1.93%

AvoidBorderlineClean

Purify ~3.1% of income

About Qiagen N.V.

QIAGEN N.V. delivers comprehensive solutions globally, converting biological specimens into actionable molecular insights. The company offers a broad range of consumables for initial sample preparation, including kits for stabilizing and purifying nucleic acids from diverse biological sources. These facilitate manual or automated processing for applications like genotyping, gene expression analysis, and detecting viral and bacterial pathogens, utilizing technologies such as silica membranes and magnetic beads. Materials for purifying nucleic acids from secondary samples are also available, alongside instruments and accessories vital for nucleic acid purification. Its diagnostic assay portfolio addresses various medical needs, from TB detection via interferon-gamma release, post-transplant monitoring, and viral load measurement, to prenatal screening and identifying STDs and HPV. The company also provides assays for analyzing genomic variations, including mutations, insertions, deletions, and fusions. Integrated sample-to-insight instrumentation supports one-step molecular analysis for complex syndromes and streamlined PCR testing. Furthermore, QIAGEN supplies PCR consumables like quantitative PCR and reverse transcription kits, used in gene expression, genotyping, and gene regulation studies, along with associated instruments and technologies. Solutions extend to human identification and forensics, featuring STR assays and food contamination testing. Their PCR instrument offerings include advanced digital PCR systems, and they develop custom OEM consumables. The company also provides Next-Generation Sequencing (NGS) products, comprising predefined and customizable gene panels, library preparation kits, and whole genome amplification tools. Complementing these are QIAGEN's general consumables, instruments, bioinformatics software, and bespoke laboratory and genomic services. Catering to a diverse client base across molecular diagnostics, academic research, pharmaceuticals, and applied testing, the company maintains strategic partnerships, including agreements with Sysmex Corporation, OncXerna Therapeutics, and Mirati. Established in 1986, its headquarters are located in Venlo, the Netherlands.

Sector: Healthcare · Industry: Medical - Diagnostics & Research

Shariah Compliance Status

AAOIFI Standard 21Updated Jun 18, 2026

C+

Fair

Some financial ratios approaching limits

55Score

Business Activity Screen

Passed

Checks if the business is involved in prohibited activities (alcohol, gambling, pork, conventional banking, etc.)

Financial Ratio Screen

Passed

Financial ratios must be below AAOIFI thresholds

Debt / Market Cap21.7% / 30.0%

Compliance History

Halal, unchanged since May 2026.

No status changes recorded since we began tracking.

Tracked since May 2026. Updates automatically on each re-screen.

Screened: Jun 18, 2026Fiscal: FY 2025Source: FMP

Purify Your QGEN Dividends

3.1% non-compliant income

QGEN has 3.1% prohibited income. Calculate exactly how much of your dividends to donate.

Financial Overview

Market Cap

7.6B

Price

$37.02

Sector

Healthcare

Industry

Medical - Diagnostics & Research

More Healthcare Stocks

JNJ

Johnson & Johnson

UNH

UnitedHealth Group Incorporated

B+

ABBV

AbbVie Inc.

PFE

Pfizer Inc.

LLY

Eli Lilly and Company

A+

MRK

Merck & Co., Inc.

B+

Free · No credit card required

Track QGEN and 10,000+ stocks with AI insights

Create your free account to unlock AI-powered compliance analysis, track your portfolio, calculate purification, and get unlimited AAOIFI screening.

Get Started Free Browse Screener

10,000+ assets AAOIFI standards Free watchlist

Frequently Asked Questions

Is Qiagen N.V. (QGEN) halal to invest in?

Based on AAOIFI Standard 21 screening, Qiagen N.V. (QGEN) is rated Halal with a compliance grade of C+ (Fair). It passes both the business activity screen (no primary involvement in prohibited sectors) and the quantitative financial ratio screen (debt, interest deposits, and prohibited income all below AAOIFI thresholds).

Why did Qiagen N.V. get a C+ compliance rating?

Qiagen N.V. (QGEN) received a grade of C+ (Fair) based on three AAOIFI Standard 21 financial ratios: debt-to-market-cap of 21.7% (limit 30%); interest-bearing deposits of 14.4% (limit 30%); prohibited income of 3.08% (limit 5%). The grade reflects the margin of safety across all three ratios relative to their thresholds.

What could change Qiagen N.V.'s Shariah verdict?

Qiagen N.V.'s verdict is re-evaluated at each annual re-screen. Three events could change it: (1) the debt-to-market-cap ratio crossing 30%, typically from new debt issuance or a major drop in share price; (2) interest-bearing deposits exceeding 30% of market cap; or (3) prohibited revenue (alcohol, gambling, conventional finance, etc.) exceeding 5% of total revenue. Verdict flips are tracked in the compliance history section above.

How often is Qiagen N.V. re-screened for Shariah compliance?

Qiagen N.V. (QGEN) is re-screened annually using the most recent full-year financial data from SEC filings. HalalScreener also triggers an on-demand re-screen whenever the stored data is more than 7 days old, ensuring the ratios reflect the latest available financial statements. Last screened: Jun 18, 2026.

Screened according to AAOIFI Standard No. 21 · For informational purposes only. Consult a qualified Islamic finance advisor before investing.

Disclaimer: This screening is for informational purposes only and does not constitute financial, legal, or religious advice. Compliance is evaluated using AAOIFI financial standards (debt, deposits, and prohibited income ratios) and publicly available data. Ethical, political, social, or environmental considerations are outside the scope of this screening. Individual scholars and methodologies may differ. Always consult a qualified Islamic finance advisor before making investment decisions.